Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension - No Study Results Posted

Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension (ATHENA-1)

This study has been completed.

Study NCT00617305 Information provided by Gilead Sciences

First Received: February 6, 2008 Last Updated: March 20, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2011
Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)